Bonne J. Adams - 01 Feb 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
Chief Operating Officer
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
TCON
Transactions as of
01 Feb 2023
Transactions value $
$0
Form type
4
Filing time
09 Feb 2023, 20:31:55 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Employee Stock Option (Right to Buy) Award $0 +99K $0.00 99K 01 Feb 2023 Common Stock 99K $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments on the 1st of each month thereafter.